Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells

The hypersialylated erythropoiesis stimulating agent (ESA) darbepoetin alfa was developed for the treatment of anemia, and has also been reported to have other nonerythropoietic effects. This study outlines one such effect against the toxicity of the radiocontrast medium (RCM) sodium diatrizoate (Na...

Full description

Bibliographic Details
Main Authors: Michele Andreucci, Michele Provenzano, Teresa Faga, Ida Gagliardi, Antonio Pisani, Maria Perticone, Giuseppe Coppolino, Giovambattista De Sarro, Raffaele Serra, Ashour Michael
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S221475002100069X